 | • レポートコード：MRC2-11QY01102 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は重金属中毒薬のグローバル市場について調査・分析したレポートです。種類別（ALN-TMP、デフェラシロクス、メシル酸デフェロキサミン、エメラミド、その他）市場規模、用途別（ヒ素中毒、クロム毒性、銅毒性、鉛中毒、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別重金属中毒薬の競争状況、市場シェア ・世界の重金属中毒薬市場：種類別市場規模 2015年-2020年（ALN-TMP、デフェラシロクス、メシル酸デフェロキサミン、エメラミド、その他） ・世界の重金属中毒薬市場：種類別市場規模予測 2021年-2026年（ALN-TMP、デフェラシロクス、メシル酸デフェロキサミン、エメラミド、その他） ・世界の重金属中毒薬市場：用途別市場規模 2015年-2020年（ヒ素中毒、クロム毒性、銅毒性、鉛中毒、その他） ・世界の重金属中毒薬市場：用途別市場規模予測 2021年-2026年（ヒ素中毒、クロム毒性、銅毒性、鉛中毒、その他） ・北米の重金属中毒薬市場分析：米国、カナダ ・ヨーロッパの重金属中毒薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの重金属中毒薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の重金属中毒薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの重金属中毒薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Alnylam Pharmaceuticals Inc、La Jolla Pharmaceutical Company、Medesis Pharma SA、Novartis AG、PDX Pharmaceuticals LLC ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Heavy Metal Poisoning Drugs Market
The global Heavy Metal Poisoning Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Heavy Metal Poisoning Drugs Scope and Market Size
Heavy Metal Poisoning Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Heavy Metal Poisoning Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Heavy Metal Poisoning Drugs market is segmented into
ALN-TMP
Deferasirox
Deferoxamine Mesylate
Emeramide
Others
Segment by Application, the Heavy Metal Poisoning Drugs market is segmented into
Arsenic Toxicity
Chromium Toxicity
Copper Toxicity
Lead Toxicity
Others
Regional and Country-level Analysis
The Heavy Metal Poisoning Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Heavy Metal Poisoning Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Heavy Metal Poisoning Drugs Market Share Analysis
Heavy Metal Poisoning Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Heavy Metal Poisoning Drugs business, the date to enter into the Heavy Metal Poisoning Drugs market, Heavy Metal Poisoning Drugs product introduction, recent developments, etc.
The major vendors covered:
Alnylam Pharmaceuticals Inc
La Jolla Pharmaceutical Company
Medesis Pharma SA
Novartis AG
PDX Pharmaceuticals LLC
…
1 Study Coverage
1.1 Heavy Metal Poisoning Drugs Product Introduction
1.2 Market Segments
1.3 Key Heavy Metal Poisoning Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Heavy Metal Poisoning Drugs Market Size Growth Rate by Type
1.4.2 ALN-TMP
1.4.3 Deferasirox
1.4.4 Deferoxamine Mesylate
1.4.5 Emeramide
1.4.6 Others
1.5 Market by Application
1.5.1 Global Heavy Metal Poisoning Drugs Market Size Growth Rate by Application
1.5.2 Arsenic Toxicity
1.5.3 Chromium Toxicity
1.5.4 Copper Toxicity
1.5.5 Lead Toxicity
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Heavy Metal Poisoning Drugs Market Size, Estimates and Forecasts
2.1.1 Global Heavy Metal Poisoning Drugs Revenue 2015-2026
2.1.2 Global Heavy Metal Poisoning Drugs Sales 2015-2026
2.2 Global Heavy Metal Poisoning Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Heavy Metal Poisoning Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Heavy Metal Poisoning Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Heavy Metal Poisoning Drugs Competitor Landscape by Players
3.1 Heavy Metal Poisoning Drugs Sales by Manufacturers
3.1.1 Heavy Metal Poisoning Drugs Sales by Manufacturers (2015-2020)
3.1.2 Heavy Metal Poisoning Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Heavy Metal Poisoning Drugs Revenue by Manufacturers
3.2.1 Heavy Metal Poisoning Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Heavy Metal Poisoning Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Heavy Metal Poisoning Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Heavy Metal Poisoning Drugs Revenue in 2019
3.2.5 Global Heavy Metal Poisoning Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Heavy Metal Poisoning Drugs Price by Manufacturers
3.4 Heavy Metal Poisoning Drugs Manufacturing Base Distribution, Product Types
3.4.1 Heavy Metal Poisoning Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Heavy Metal Poisoning Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Heavy Metal Poisoning Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Heavy Metal Poisoning Drugs Market Size by Type (2015-2020)
4.1.1 Global Heavy Metal Poisoning Drugs Sales by Type (2015-2020)
4.1.2 Global Heavy Metal Poisoning Drugs Revenue by Type (2015-2020)
4.1.3 Heavy Metal Poisoning Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Heavy Metal Poisoning Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Heavy Metal Poisoning Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Heavy Metal Poisoning Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Heavy Metal Poisoning Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Heavy Metal Poisoning Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Heavy Metal Poisoning Drugs Market Size by Application (2015-2020)
5.1.1 Global Heavy Metal Poisoning Drugs Sales by Application (2015-2020)
5.1.2 Global Heavy Metal Poisoning Drugs Revenue by Application (2015-2020)
5.1.3 Heavy Metal Poisoning Drugs Price by Application (2015-2020)
5.2 Heavy Metal Poisoning Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Heavy Metal Poisoning Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Heavy Metal Poisoning Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Heavy Metal Poisoning Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Heavy Metal Poisoning Drugs by Country
6.1.1 North America Heavy Metal Poisoning Drugs Sales by Country
6.1.2 North America Heavy Metal Poisoning Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Heavy Metal Poisoning Drugs Market Facts & Figures by Type
6.3 North America Heavy Metal Poisoning Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Heavy Metal Poisoning Drugs by Country
7.1.1 Europe Heavy Metal Poisoning Drugs Sales by Country
7.1.2 Europe Heavy Metal Poisoning Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Heavy Metal Poisoning Drugs Market Facts & Figures by Type
7.3 Europe Heavy Metal Poisoning Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Heavy Metal Poisoning Drugs by Region
8.1.1 Asia Pacific Heavy Metal Poisoning Drugs Sales by Region
8.1.2 Asia Pacific Heavy Metal Poisoning Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Heavy Metal Poisoning Drugs Market Facts & Figures by Type
8.3 Asia Pacific Heavy Metal Poisoning Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Heavy Metal Poisoning Drugs by Country
9.1.1 Latin America Heavy Metal Poisoning Drugs Sales by Country
9.1.2 Latin America Heavy Metal Poisoning Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Heavy Metal Poisoning Drugs Market Facts & Figures by Type
9.3 Central & South America Heavy Metal Poisoning Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Heavy Metal Poisoning Drugs by Country
10.1.1 Middle East and Africa Heavy Metal Poisoning Drugs Sales by Country
10.1.2 Middle East and Africa Heavy Metal Poisoning Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Heavy Metal Poisoning Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Heavy Metal Poisoning Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Alnylam Pharmaceuticals Inc
11.1.1 Alnylam Pharmaceuticals Inc Corporation Information
11.1.2 Alnylam Pharmaceuticals Inc Description and Business Overview
11.1.3 Alnylam Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alnylam Pharmaceuticals Inc Heavy Metal Poisoning Drugs Products Offered
11.1.5 Alnylam Pharmaceuticals Inc Related Developments
11.2 La Jolla Pharmaceutical Company
11.2.1 La Jolla Pharmaceutical Company Corporation Information
11.2.2 La Jolla Pharmaceutical Company Description and Business Overview
11.2.3 La Jolla Pharmaceutical Company Sales, Revenue and Gross Margin (2015-2020)
11.2.4 La Jolla Pharmaceutical Company Heavy Metal Poisoning Drugs Products Offered
11.2.5 La Jolla Pharmaceutical Company Related Developments
11.3 Medesis Pharma SA
11.3.1 Medesis Pharma SA Corporation Information
11.3.2 Medesis Pharma SA Description and Business Overview
11.3.3 Medesis Pharma SA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Medesis Pharma SA Heavy Metal Poisoning Drugs Products Offered
11.3.5 Medesis Pharma SA Related Developments
11.4 Novartis AG
11.4.1 Novartis AG Corporation Information
11.4.2 Novartis AG Description and Business Overview
11.4.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis AG Heavy Metal Poisoning Drugs Products Offered
11.4.5 Novartis AG Related Developments
11.5 PDX Pharmaceuticals LLC
11.5.1 PDX Pharmaceuticals LLC Corporation Information
11.5.2 PDX Pharmaceuticals LLC Description and Business Overview
11.5.3 PDX Pharmaceuticals LLC Sales, Revenue and Gross Margin (2015-2020)
11.5.4 PDX Pharmaceuticals LLC Heavy Metal Poisoning Drugs Products Offered
11.5.5 PDX Pharmaceuticals LLC Related Developments
11.1 Alnylam Pharmaceuticals Inc
11.1.1 Alnylam Pharmaceuticals Inc Corporation Information
11.1.2 Alnylam Pharmaceuticals Inc Description and Business Overview
11.1.3 Alnylam Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alnylam Pharmaceuticals Inc Heavy Metal Poisoning Drugs Products Offered
11.1.5 Alnylam Pharmaceuticals Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Heavy Metal Poisoning Drugs Market Estimates and Projections by Region
12.1.1 Global Heavy Metal Poisoning Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Heavy Metal Poisoning Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Heavy Metal Poisoning Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Heavy Metal Poisoning Drugs Sales Forecast (2021-2026)
12.2.2 North America: Heavy Metal Poisoning Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Heavy Metal Poisoning Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Heavy Metal Poisoning Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Heavy Metal Poisoning Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Heavy Metal Poisoning Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Heavy Metal Poisoning Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Heavy Metal Poisoning Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Heavy Metal Poisoning Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Heavy Metal Poisoning Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Heavy Metal Poisoning Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Heavy Metal Poisoning Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Heavy Metal Poisoning Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Heavy Metal Poisoning Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Heavy Metal Poisoning Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Heavy Metal Poisoning Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Heavy Metal Poisoning Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Heavy Metal Poisoning Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Heavy Metal Poisoning Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Heavy Metal Poisoning Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Heavy Metal Poisoning Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Heavy Metal Poisoning Drugs Market Segments
Table 2. Ranking of Global Top Heavy Metal Poisoning Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Heavy Metal Poisoning Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ALN-TMP
Table 5. Major Manufacturers of Deferasirox
Table 6. Major Manufacturers of Deferoxamine Mesylate
Table 7. Major Manufacturers of Emeramide
Table 8. Major Manufacturers of Others
Table 9. Global Heavy Metal Poisoning Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Heavy Metal Poisoning Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Heavy Metal Poisoning Drugs Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Heavy Metal Poisoning Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Heavy Metal Poisoning Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Heavy Metal Poisoning Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Heavy Metal Poisoning Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Heavy Metal Poisoning Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Heavy Metal Poisoning Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heavy Metal Poisoning Drugs as of 2019)
Table 18. Heavy Metal Poisoning Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Heavy Metal Poisoning Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Heavy Metal Poisoning Drugs Price (2015-2020) (USD/Pcs)
Table 21. Heavy Metal Poisoning Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Heavy Metal Poisoning Drugs Product Type
Table 23. Date of International Manufacturers Enter into Heavy Metal Poisoning Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Heavy Metal Poisoning Drugs Sales by Type (2015-2020) (K Pcs)
Table 26. Global Heavy Metal Poisoning Drugs Sales Share by Type (2015-2020)
Table 27. Global Heavy Metal Poisoning Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Heavy Metal Poisoning Drugs Revenue Share by Type (2015-2020)
Table 29. Heavy Metal Poisoning Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Heavy Metal Poisoning Drugs Sales by Application (2015-2020) (K Pcs)
Table 31. Global Heavy Metal Poisoning Drugs Sales Share by Application (2015-2020)
Table 32. North America Heavy Metal Poisoning Drugs Sales by Country (2015-2020) (K Pcs)
Table 33. North America Heavy Metal Poisoning Drugs Sales Market Share by Country (2015-2020)
Table 34. North America Heavy Metal Poisoning Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Heavy Metal Poisoning Drugs Revenue Market Share by Country (2015-2020)
Table 36. North America Heavy Metal Poisoning Drugs Sales by Type (2015-2020) (K Pcs)
Table 37. North America Heavy Metal Poisoning Drugs Sales Market Share by Type (2015-2020)
Table 38. North America Heavy Metal Poisoning Drugs Sales by Application (2015-2020) (K Pcs)
Table 39. North America Heavy Metal Poisoning Drugs Sales Market Share by Application (2015-2020)
Table 40. Europe Heavy Metal Poisoning Drugs Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Heavy Metal Poisoning Drugs Sales Market Share by Country (2015-2020)
Table 42. Europe Heavy Metal Poisoning Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Heavy Metal Poisoning Drugs Revenue Market Share by Country (2015-2020)
Table 44. Europe Heavy Metal Poisoning Drugs Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Heavy Metal Poisoning Drugs Sales Market Share by Type (2015-2020)
Table 46. Europe Heavy Metal Poisoning Drugs Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Heavy Metal Poisoning Drugs Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Heavy Metal Poisoning Drugs Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Heavy Metal Poisoning Drugs Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Heavy Metal Poisoning Drugs Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Heavy Metal Poisoning Drugs Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Heavy Metal Poisoning Drugs Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Heavy Metal Poisoning Drugs Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Heavy Metal Poisoning Drugs Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Heavy Metal Poisoning Drugs Sales Market Share by Application (2015-2020)
Table 56. Latin America Heavy Metal Poisoning Drugs Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Heavy Metal Poisoning Drugs Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Heavy Metal Poisoning Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Heavy Metal Poisoning Drugs Revenue Market Share by Country (2015-2020)
Table 60. Latin America Heavy Metal Poisoning Drugs Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Heavy Metal Poisoning Drugs Sales Market Share by Type (2015-2020)
Table 62. Latin America Heavy Metal Poisoning Drugs Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Heavy Metal Poisoning Drugs Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Heavy Metal Poisoning Drugs Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Heavy Metal Poisoning Drugs Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Heavy Metal Poisoning Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Heavy Metal Poisoning Drugs Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Heavy Metal Poisoning Drugs Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Heavy Metal Poisoning Drugs Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Heavy Metal Poisoning Drugs Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Heavy Metal Poisoning Drugs Sales Market Share by Application (2015-2020)
Table 72. Alnylam Pharmaceuticals Inc Corporation Information
Table 73. Alnylam Pharmaceuticals Inc Description and Major Businesses
Table 74. Alnylam Pharmaceuticals Inc Heavy Metal Poisoning Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Alnylam Pharmaceuticals Inc Product
Table 76. Alnylam Pharmaceuticals Inc Recent Development
Table 77. La Jolla Pharmaceutical Company Corporation Information
Table 78. La Jolla Pharmaceutical Company Description and Major Businesses
Table 79. La Jolla Pharmaceutical Company Heavy Metal Poisoning Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. La Jolla Pharmaceutical Company Product
Table 81. La Jolla Pharmaceutical Company Recent Development
Table 82. Medesis Pharma SA Corporation Information
Table 83. Medesis Pharma SA Description and Major Businesses
Table 84. Medesis Pharma SA Heavy Metal Poisoning Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Medesis Pharma SA Product
Table 86. Medesis Pharma SA Recent Development
Table 87. Novartis AG Corporation Information
Table 88. Novartis AG Description and Major Businesses
Table 89. Novartis AG Heavy Metal Poisoning Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Novartis AG Product
Table 91. Novartis AG Recent Development
Table 92. PDX Pharmaceuticals LLC Corporation Information
Table 93. PDX Pharmaceuticals LLC Description and Major Businesses
Table 94. PDX Pharmaceuticals LLC Heavy Metal Poisoning Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. PDX Pharmaceuticals LLC Product
Table 96. PDX Pharmaceuticals LLC Recent Development
Table 97. Global Heavy Metal Poisoning Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 98. Global Heavy Metal Poisoning Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 99. Global Heavy Metal Poisoning Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 100. Global Heavy Metal Poisoning Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 101. North America: Heavy Metal Poisoning Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 102. North America: Heavy Metal Poisoning Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Europe: Heavy Metal Poisoning Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. Europe: Heavy Metal Poisoning Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Asia Pacific: Heavy Metal Poisoning Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 106. Asia Pacific: Heavy Metal Poisoning Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 107. Latin America: Heavy Metal Poisoning Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Latin America: Heavy Metal Poisoning Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Middle East and Africa: Heavy Metal Poisoning Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Middle East and Africa: Heavy Metal Poisoning Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 112. Key Challenges
Table 113. Market Risks
Table 114. Main Points Interviewed from Key Heavy Metal Poisoning Drugs Players
Table 115. Heavy Metal Poisoning Drugs Customers List
Table 116. Heavy Metal Poisoning Drugs Distributors List
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Heavy Metal Poisoning Drugs Product Picture
Figure 2. Global Heavy Metal Poisoning Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. ALN-TMP Product Picture
Figure 4. Deferasirox Product Picture
Figure 5. Deferoxamine Mesylate Product Picture
Figure 6. Emeramide Product Picture
Figure 7. Others Product Picture
Figure 8. Global Heavy Metal Poisoning Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Arsenic Toxicity
Figure 10. Chromium Toxicity
Figure 11. Copper Toxicity
Figure 12. Lead Toxicity
Figure 13. Others
Figure 14. Heavy Metal Poisoning Drugs Report Years Considered
Figure 15. Global Heavy Metal Poisoning Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global Heavy Metal Poisoning Drugs Sales 2015-2026 (K Pcs)
Figure 17. Global Heavy Metal Poisoning Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Heavy Metal Poisoning Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Heavy Metal Poisoning Drugs Sales Market Share by Region in 2019
Figure 20. Global Heavy Metal Poisoning Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Heavy Metal Poisoning Drugs Revenue Market Share by Region in 2019
Figure 22. Global Heavy Metal Poisoning Drugs Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Heavy Metal Poisoning Drugs Revenue in 2019
Figure 24. Heavy Metal Poisoning Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Heavy Metal Poisoning Drugs Sales Market Share by Type (2015-2020)
Figure 26. Global Heavy Metal Poisoning Drugs Sales Market Share by Type in 2019
Figure 27. Global Heavy Metal Poisoning Drugs Revenue Market Share by Type (2015-2020)
Figure 28. Global Heavy Metal Poisoning Drugs Revenue Market Share by Type in 2019
Figure 29. Global Heavy Metal Poisoning Drugs Market Share by Price Range (2015-2020)
Figure 30. Global Heavy Metal Poisoning Drugs Sales Market Share by Application (2015-2020)
Figure 31. Global Heavy Metal Poisoning Drugs Sales Market Share by Application in 2019
Figure 32. Global Heavy Metal Poisoning Drugs Revenue Market Share by Application (2015-2020)
Figure 33. Global Heavy Metal Poisoning Drugs Revenue Market Share by Application in 2019
Figure 34. North America Heavy Metal Poisoning Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Heavy Metal Poisoning Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Heavy Metal Poisoning Drugs Sales Market Share by Country in 2019
Figure 37. North America Heavy Metal Poisoning Drugs Revenue Market Share by Country in 2019
Figure 38. U.S. Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Heavy Metal Poisoning Drugs Market Share by Type in 2019
Figure 43. North America Heavy Metal Poisoning Drugs Market Share by Application in 2019
Figure 44. Europe Heavy Metal Poisoning Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Heavy Metal Poisoning Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Heavy Metal Poisoning Drugs Sales Market Share by Country in 2019
Figure 47. Europe Heavy Metal Poisoning Drugs Revenue Market Share by Country in 2019
Figure 48. Germany Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Heavy Metal Poisoning Drugs Market Share by Type in 2019
Figure 59. Europe Heavy Metal Poisoning Drugs Market Share by Application in 2019
Figure 60. Asia Pacific Heavy Metal Poisoning Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Heavy Metal Poisoning Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Heavy Metal Poisoning Drugs Sales Market Share by Region in 2019
Figure 63. Asia Pacific Heavy Metal Poisoning Drugs Revenue Market Share by Region in 2019
Figure 64. China Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Heavy Metal Poisoning Drugs Market Share by Type in 2019
Figure 87. Asia Pacific Heavy Metal Poisoning Drugs Market Share by Application in 2019
Figure 88. Latin America Heavy Metal Poisoning Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Heavy Metal Poisoning Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Heavy Metal Poisoning Drugs Sales Market Share by Country in 2019
Figure 91. Latin America Heavy Metal Poisoning Drugs Revenue Market Share by Country in 2019
Figure 92. Mexico Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Heavy Metal Poisoning Drugs Market Share by Type in 2019
Figure 99. Latin America Heavy Metal Poisoning Drugs Market Share by Application in 2019
Figure 100. Middle East and Africa Heavy Metal Poisoning Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Heavy Metal Poisoning Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Heavy Metal Poisoning Drugs Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Heavy Metal Poisoning Drugs Revenue Market Share by Country in 2019
Figure 104. Turkey Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Heavy Metal Poisoning Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Heavy Metal Poisoning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Heavy Metal Poisoning Drugs Market Share by Type in 2019
Figure 111. Middle East and Africa Heavy Metal Poisoning Drugs Market Share by Application in 2019
Figure 112. North America Heavy Metal Poisoning Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Heavy Metal Poisoning Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Heavy Metal Poisoning Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Heavy Metal Poisoning Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Heavy Metal Poisoning Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Heavy Metal Poisoning Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Heavy Metal Poisoning Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Heavy Metal Poisoning Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Heavy Metal Poisoning Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Heavy Metal Poisoning Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
厚肉溶接パイプの世界市場（～2026年） Heavy wall welded pipes, called the heavy wall welded pipes, have a welded pipe whose outer diameter and wall thickness ratio is less than 20. From a regional perspective, the heavy wall welded pipes market in the Asia Pacific region is anticipated to dominate the market in terms of volume and value…- 重油の世界市場（～2026年） Market Analysis and Insights: Global Heavy Oil Market The global Heavy Oil market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Heavy Oil Scope and Market Size Heavy Oil market is segmented by Type, and by Application. Play…
- 大型トラックオンボード診断システムの世界市場（～2026年） With the improving sales of OBDs, OEMs are emphasizing on the integration of electronic systems in the overall functionality and operations of vehicles. Market Analysis and Insights: Global Heavy Trucks On-board Diagnostics System Market The global Heavy Trucks On-board Diagnostics System market siz…
- 重炭酸カルシウムの世界市場（～2026年） Market Analysis and Insights: Global Heavy Calcium Carbonate Market The global Heavy Calcium Carbonate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Heavy Calcium Carbonate Scope and Market Size Heavy Calcium Carbona…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…